These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
910 related articles for article (PubMed ID: 16235347)
41. Tacrolimus versus cyclosporin immunosuppression: long-term outcome in renal transplantation. Jurewicz WA Nephrol Dial Transplant; 2003 May; 18 Suppl 1():i7-11. PubMed ID: 12738757 [TBL] [Abstract][Full Text] [Related]
42. Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation. Plosker GL; Foster RH Drugs; 2000 Feb; 59(2):323-89. PubMed ID: 10730553 [TBL] [Abstract][Full Text] [Related]
43. Impact of Mycophenolate Mofetil Dose Reduction on Allograft Outcomes in Kidney Transplant Recipients on Tacrolimus-Based Regimens: A Systematic Review. Su VCh; Greanya ED; Ensom MH Ann Pharmacother; 2011 Feb; 45(2):248-57. PubMed ID: 21304036 [TBL] [Abstract][Full Text] [Related]
44. Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis. McAlister VC; Haddad E; Renouf E; Malthaner RA; Kjaer MS; Gluud LL Am J Transplant; 2006 Jul; 6(7):1578-85. PubMed ID: 16827858 [TBL] [Abstract][Full Text] [Related]
45. Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients. Gathogo E; Harber M; Bhagani S; Levy J; Jones R; Hilton R; Davies G; Post FA; Transplantation; 2016 Apr; 100(4):871-8. PubMed ID: 26413990 [TBL] [Abstract][Full Text] [Related]
47. Increased early rejection rate after conversion from tacrolimus in kidney and pancreas transplantation. Barone GW; Ketel BL; Abul-Ezz SR; Lightfoot ML JOP; 2002 Mar; 3(2):49-53. PubMed ID: 11884766 [TBL] [Abstract][Full Text] [Related]
48. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Pirsch JD; Miller J; Deierhoi MH; Vincenti F; Filo RS Transplantation; 1997 Apr; 63(7):977-83. PubMed ID: 9112351 [TBL] [Abstract][Full Text] [Related]
49. mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis. Xie X; Jiang Y; Lai X; Xiang S; Shou Z; Chen J BMC Nephrol; 2015 Jul; 16():91. PubMed ID: 26126806 [TBL] [Abstract][Full Text] [Related]
50. Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review. Knight SR; Russell NK; Barcena L; Morris PJ Transplantation; 2009 Mar; 87(6):785-94. PubMed ID: 19300178 [TBL] [Abstract][Full Text] [Related]
52. No difference in degree of interstitial Sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year. Rowshani AT; Scholten EM; Bemelman F; Eikmans M; Idu M; Roos-van Groningen MC; Surachno JS; Mallat MJ; Paul LC; de Fijter JW; Bajema IM; ten Berge I; Florquin S J Am Soc Nephrol; 2006 Jan; 17(1):305-12. PubMed ID: 16306168 [TBL] [Abstract][Full Text] [Related]
53. Immunosuppressive drugs in paediatric liver transplantation. van Mourik ID; Kelly DA Paediatr Drugs; 2001; 3(1):43-60. PubMed ID: 11220404 [TBL] [Abstract][Full Text] [Related]
54. Tacrolimus in transplant rejection. Rath T Expert Opin Pharmacother; 2013 Jan; 14(1):115-22. PubMed ID: 23228138 [TBL] [Abstract][Full Text] [Related]
55. Fish oil for kidney transplant recipients. Lim AK; Manley KJ; Roberts MA; Fraenkel MB Cochrane Database Syst Rev; 2007 Apr; (2):CD005282. PubMed ID: 17443580 [TBL] [Abstract][Full Text] [Related]
56. Sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids: focus on acute rejection, patient and graft survival. Yang A; Wang B Am J Ther; 2015; 22(2):98-104. PubMed ID: 23921809 [TBL] [Abstract][Full Text] [Related]
57. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year. Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989 [TBL] [Abstract][Full Text] [Related]
59. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation. Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415 [TBL] [Abstract][Full Text] [Related]
60. A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin. Rolles K; Davidson BR; Burroughs AK Transplantation; 1999 Oct; 68(8):1195-8. PubMed ID: 10551650 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]